Subjects and methods
The lactulose breath hydrogen test was performed in three study groups. (1) This group comprised 10 patients with Duchenne muscular dystrophy who were confined to a wheelchair; their mean (SD) age was 17-0 (1-8) years, range 15-20. (2) This group comprised 10 patients (seven boys) with other neuromuscular disorders (congenital muscular dystrophy (n=3), limb girdle muscular dystrophy (n=3), spinal muscular atrophy type II (n=3), and hereditary motor and sensory neuropathy (n= 1)); they were aged 14-5 (3 0) years, range [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Mean (SD) orocaecal transit time was 68-0 (20 4) minutes in controls, 69-0 (21 3) minutes in the patients with Duchenne muscular dystrophy, and 58 0 (17-5) minutes in the patients with other neuromuscular disorders ( fig 2) . There was no significant difference between the groups (p=0 55, Kruskal-Wallis test).
Discussion
Despite postmortem evidence of significant gastrointestinal smooth muscle degeneration in Duchenne muscular dystrophy, 1-3 little attention has been paid to studying its functional consequences. Barohn et al recently documented gastric hypomotility in Duchenne muscular dystrophy patients and postulated that it may be related to a deficiency of dystrophin, the gene product of the Duchenne muscular dystrophy locus. 3 We found no evidence of delayed fasting orocaecal transit time in either Duchenne muscular dystrophy or other neuromuscular disorders. Our results do not exclude the possibility of delayed gastric emptying in our patients. The orocaecal transit time as measured by the lactulose breath hydrogen test is dependent solely on small intestinal transit time and is not influenced by gastric emptying time.4 7 This is because orocaecal transit time is determined by the time taken for the head (rather than the bulk) of the lactulose column to reach the caecum. Even if gastric emptying is significantly delayed, a small amount of lactulose will still pass through the pylorus almost immediately after ingestion.
There is no uniformly accepted methodology for determination of orocaecal transit time using the lactulose breath hydrogen test. We measured it using a solution of lactulose in the fasting state only. This straightforward method has been successfully used to demonstrate the influence on intestinal transit of various states such as cystic fibrosis,8 thyroid disease,9 and aerobic exercise.'0 Determination of postprandial orocaecal transit time using standard liquid " or solid'2 meals has been shown to improve the reproducibility of the test. We cannot exclude the possibility that subjects with Duchenne muscular dystrophy may have an abnormality in small intestinal motility detectable only in the postprandial state.
The apparent discrepancy between our finding of normal small intestinal motility in contrast to the gastric hypomotility in Duchenne muscular dystrophy described by Barohn et al is unlikely to be due to a difference in the patients studied3; the mean age of both groups was almost identical, and all of our patients were confined to wheelchairs. A more likely explanation supported by histological findings from postmortem studies is that the degenerative process predominantly affects the upper gastrointestinal smooth muscle. 3 Some patients with Duchenne muscular dystrophy suffer from constipation. Our findings suggest that the constipation is not due to impaired small intestinal motility. Colonic motility, another possible factor in the genesis of constipation, has not yet been studied in Duchenne muscular dystrophy. Most likely, however, the constipation in these patients is related to their immobility and weakness of their abdominal wall musculature.
Despite our finding of normal fasting small intestinal transit time, we cannot exclude the presence of small intestinal smooth muscle degeneration in our patients as such changes have been demonstrated at postmortem examination in the absence of overt clinical symptoms.' We can, however, conclude that we have found no evidence for impairment of small intestinal motility even in advanced Duchenne muscular dystrophy.
